Behavioral interventions in multiple sclerosis: a biopsychosocial perspective

References

• Kesselring J. Multiple Sklerose. Kohlhammer, Stuttgart, Köln, Berlin (1989).
   Google Scholar
• Rudick RA, Miller AE. Multiple sclerosis or multiple possibilities: the continuing problem of misdiagnosis. Neurology 78(24), 1904–1906 (2012).
   PubMed Web of Science ®Google Scholar
• Aktas O, Kieseier B, Hartung HP. Neuroprotection, regeneration and immunomodulation: broadening the therapeutic repertoire in multiple sclerosis. Trends Neurosci. 33(3), 140–152 (2010).
   PubMed Web of Science ®Google Scholar
• Bruce JM, Hancock LM, Arnett P, Lynch S. Treatment adherence in multiple sclerosis: association with emotional status, personality, and cognition. J. Behav. Med. 33(3), 219–227 (2010).
   PubMed Web of Science ®Google Scholar
• Mishel MH. Reconceptualization of the uncertainty in illness theory. Image. J. Nurs. Sch. 22(4), 256–262 (1990).
   PubMedGoogle Scholar
• Fischer A, Heesen C, Gold SM. Biological outcome measurements for behavioral interventions in multiple sclerosis. Ther. Adv. Neurol. Disord. 4(4), 217–229 (2011).
   PubMedGoogle Scholar
• Li J, Johansen C, Brønnum-Hansen H, Stenager E, Koch-Henriksen N, Olsen J. The risk of multiple sclerosis in bereaved parents: a nationwide cohort study in Denmark. Neurology 62(5), 726–729 (2004).
   PubMed Web of Science ®Google Scholar
• Lupien SJ, McEwen BS, Gunnar MR, Heim C. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat. Rev. Neurosci. 10(6), 434–445 (2009).
   PubMed Web of Science ®Google Scholar
• Riise T, Mohr DC, Munger KL, Rich-Edwards JW, Kawachi I, Ascherio A. Stress and the risk of multiple sclerosis. Neurology 76(22), 1866–1871 (2011).
   Google Scholar
• Spitzer C, Bouchain M, Winkler LY et al. Childhood trauma in multiple sclerosis: a case–control study. Psychosom. Med. 74(3), 312–318 (2012).
   Google Scholar
• Charcot JM. Lectures on the Diseases of the Nervous System. New Sydenham Society, London, UK (1877).
   Google Scholar
• Artemiadis AK, Anagnostouli MC, Alexopoulos EC. Stress as a risk factor for multiple sclerosis onset or relapse: a systematic review. Neuroepidemiology 36(2), 109–120 (2011).
   PubMed Web of Science ®Google Scholar
• Mohr DC, Goodkin DE, Bacchetti P et al. Psychological stress and the subsequent appearance of new brain MRI lesions in MS. Neurology 55(1), 55–61 (2000).
   PubMed Web of Science ®Google Scholar
• Golan D, Somer E, Dishon S, Cuzin-Disegni L, Miller A. Impact of exposure to war stress on exacerbations of multiple sclerosis. Ann. Neurol. 64(2), 143–148 (2008).
   Google Scholar
• Yamout B, Itani S, Hourany R, Sibaii AM, Yaghi S. The effect of war stress on multiple sclerosis exacerbations and radiological disease activity. J. Neurol. Sci. 288(1–2), 42–44 (2010).
   PubMed Web of Science ®Google Scholar
• Patten SB, Beck CA, Williams JV, Barbui C, Metz LM. Major depression in multiple sclerosis: a population-based perspective. Neurology 61(11), 1524–1527 (2003).
   PubMed Web of Science ®Google Scholar
• Feinstein A. Multiple sclerosis and depression. Mult. Scler. 17(11), 1276–1281 (2011).
   PubMed Web of Science ®Google Scholar
• Julian LJ, Vella L, Vollmer T, Hadjimichael O, Mohr DC. Employment in multiple sclerosis. Exiting and re-entering the work force. J. Neurol. 255(9), 1354–1360 (2008).
   PubMed Web of Science ®Google Scholar
• Feuillet L, Reuter F, Audoin B et al. Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis. Mult. Scler. 13(1), 124–127 (2007).
   PubMed Web of Science ®Google Scholar
• Filippi M, Rocca MA, Benedict RH et al. The contribution of MRI in assessing cognitive impairment in multiple sclerosis. Neurology 75(23), 2121–2128 (2010).
   PubMed Web of Science ®Google Scholar
• Henry A, Tourbah A, Chaunu MP, Rumbach L, Montreuil M, Bakchine S. Social cognition impairments in relapsing-remitting multiple sclerosis. J. Int. Neuropsychol. Soc. 17(6), 1122–1131 (2011).
   PubMed Web of Science ®Google Scholar
• Mohr DC, Genain C. Social support as a buffer in the relationship between treatment for depression and T-cell production of interferon-γ in patients with multiple sclerosis. J. Psychosom. Res. 57(2), 155–158 (2004).
   PubMed Web of Science ®Google Scholar
• Ehrensperger MM, Grether A, Romer G et al. Neuropsychological dysfunction, depression, physical disability, and coping processes in families with a parent affected by multiple sclerosis. Mult. Scler. 14(8), 1106–1112 (2008).
   PubMed Web of Science ®Google Scholar
• Ebers GC, Traboulsee A, Li D et al; Investigators of the 16-year long-term follow-up study. Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNβ-1b trial. J. Neurol. Neurosurg. Psychiatr. 81(8), 907–912 (2010).
   PubMed Web of Science ®Google Scholar
• Heesen C, Kleiter I, Nguyen F et al. Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists. Mult. Scler. 16(12), 1507–1512 (2010).
   PubMed Web of Science ®Google Scholar
• Fischer JS, Priore RL, Jacobs LD et al. Neuropsychological effects of interferon β-1a in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research Group. Ann. Neurol. 48(6), 885–892 (2000).
   PubMed Web of Science ®Google Scholar
• Benedict RH, Zivadinov R. Risk factors for and management of cognitive dysfunction in multiple sclerosis. Nat. Rev. Neurol. 7(6), 332–342 (2011).
   PubMed Web of Science ®Google Scholar
• Koch MW, Glazenborg A, Uyttenboogaart M, Mostert J, De Keyser J. Pharmacologic treatment of depression in multiple sclerosis. Cochrane Database Syst. Rev. 2, CD007295 (2011).
   Google Scholar
• Plow MA, Finlayson M, Rezac M. A scoping review of self-management interventions for adults with multiple sclerosis. PM R 3(3), 251–262 (2011).
   PubMedGoogle Scholar
• Lejbkowicz I, Caspi O, Miller A. Participatory medicine and patient empowerment towards personalized healthcare in multiple sclerosis. Expert Rev. Neurother. 12(3), 343–352 (2012).
   PubMed Web of Science ®Google Scholar
• Bunge M, Mühlhauser I, Steckelberg A. What constitutes evidence-based patient information? Overview of discussed criteria. Patient Educ. Couns. 78(3), 316–328 (2010).
   PubMed Web of Science ®Google Scholar
• Hawe P, Shiell A, Riley T. Complex interventions: how ‘out of control’ can a randomised controlled trial be? BMJ 328(7455), 1561–1563 (2004).
   PubMed Web of Science ®Google Scholar
• Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M; Medical Research Council Guidance. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 337, a1655 (2008).
   PubMed Web of Science ®Google Scholar
• Motl RW, Gosney JL. Effect of exercise training on quality of life in multiple sclerosis: a meta-analysis. Mult. Scler. 14(1), 129–135 (2008).
   PubMed Web of Science ®Google Scholar
• Asano M, Dawes DJ, Arafah A, Moriello C, Mayo NE. What does a structured review of the effectiveness of exercise interventions for persons with multiple sclerosis tell us about the challenges of designing trials? Mult. Scler. 15(4), 412–421 (2009).
   PubMed Web of Science ®Google Scholar
• Dalgas U, Stenager E, Jakobsen J et al. Resistance training improves muscle strength and functional capacity in multiple sclerosis. Neurology 73(18), 1478–1484 (2009).
   PubMed Web of Science ®Google Scholar
• Tallner A, Waschbisch A, Wenny I et al. Multiple sclerosis relapses are not associated with exercise. Mult. Scler. 18(2), 232–235 (2012).
   PubMed Web of Science ®Google Scholar
• Schulz KH, Gold SM, Witte J et al. Impact of aerobic training on immune-endocrine parameters, neurotrophic factors, quality of life and coordinative function in multiple sclerosis. J. Neurol. Sci. 225(1–2), 11–18 (2004).
   PubMed Web of Science ®Google Scholar
• Snook EM, Motl RW. Effect of exercise training on walking mobility in multiple sclerosis: a meta-analysis. Neurorehabil. Neural Repair 23(2), 108–116 (2009).
   PubMed Web of Science ®Google Scholar
• Andreasen AK, Stenager E, Dalgas U. The effect of exercise therapy on fatigue in multiple sclerosis. Mult. Scler. 17(9), 1041–1054 (2011).
   PubMed Web of Science ®Google Scholar
• Dalgas U, Stenager E. Exercise and disease progression in multiple sclerosis: can exercise slow down the progression of multiple sclerosis? Ther. Adv. Neurol. Disord. 5(2), 81–95 (2012).
   PubMed Web of Science ®Google Scholar
• Hillman CH, Erickson KI, Kramer AF. Be smart, exercise your heart: exercise effects on brain and cognition. Nat. Rev. Neurosci. 9(1), 58–65 (2008).
   PubMed Web of Science ®Google Scholar
• Smith PJ, Blumenthal JA, Hoffman BM et al. Aerobic exercise and neurocognitive performance: a meta-analytic review of randomized controlled trials. Psychosom. Med. 72(3), 239–252 (2010).
   PubMed Web of Science ®Google Scholar
• Motl RW, Sandroff BM, Benedict RH. Cognitive dysfunction and multiple sclerosis: developing a rationale for considering the efficacy of exercise training. Mult. Scler. 17(9), 1034–1040 (2011).
   PubMed Web of Science ®Google Scholar
• Oken BS, Kishiyama S, Zajdel D et al. Randomized controlled trial of yoga and exercise in multiple sclerosis. Neurology 62(11), 2058–2064 (2004).
   PubMed Web of Science ®Google Scholar
• Prakash RS, Patterson B, Janssen A, Abduljalil A, Boster A. Physical activity associated with increased resting-state functional connectivity in multiple sclerosis. J. Int. Neuropsychol. Soc. 17(6), 986–997 (2011).
   PubMed Web of Science ®Google Scholar
• Prakash RS, Snook EM, Motl RW, Kramer AF. Aerobic fitness is associated with gray matter volume and white matter integrity in multiple sclerosis. Brain Res. 1341, 41–51 (2010).
   PubMed Web of Science ®Google Scholar
• Rietberg MB, Brooks D, Uitdehaag BM, Kwakkel G. Exercise therapy for multiple sclerosis. Cochrane Database Syst. Rev. 1, CD003980 (2005).
   PubMedGoogle Scholar
• Rasova K, Feys P, Henze T et al. Emerging evidence-based physical rehabilitation for multiple sclerosis – towards an inventory of current content across Europe. Health Qual. Life Outcomes 8, 76 (2010).
   PubMed Web of Science ®Google Scholar
• Motl RW, Dlugonski D, Wójcicki TR, McAuley E, Mohr DC. Internet intervention for increasing physical activity in persons with multiple sclerosis. Mult. Scler. 17(1), 116–128 (2011).
   PubMed Web of Science ®Google Scholar
• Coulter A. Evidence based patient information is important, so there needs to be a national strategy to ensure it. BMJ 317(7153), 225–226 (1998).
   PubMed Web of Science ®Google Scholar
• Stacey D, Bennett CL, Barry MJ et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst. Rev. 10, CD001431 (2011).
   PubMed Web of Science ®Google Scholar
• Stacey D, Kryworuchko J, Bennett C, Murray MA, Mullan S, Légaré F. Decision coaching to prepare patients for making health decisions: a systematic review of decision coaching in trials of patient decision AIDS. Med. Decis. Making 32(3), E22–E33 (2012).
   PubMed Web of Science ®Google Scholar
• Coulter A, Ellins J. Effectiveness of strategies for informing, educating, and involving patients. BMJ 335(7609), 24–27 (2007).
   PubMed Web of Science ®Google Scholar
• Heesen C, Schulz KH, Fiehler J et al. Correlates of cognitive dysfunction in multiple sclerosis. Brain Behav. Immun. 24(7), 1148–1155 (2010).
   PubMed Web of Science ®Google Scholar
• Köpke S, Solari A, Khan F, Heesen C, Giordano A. Information provision for persons with multiple sclerosis (protocol). Cochrane Database Syst. Rev. 10, CD008757 (2010).
   Google Scholar
• Ennis M, Thain J, Boggild M, Baker GA, Young CA. A randomized controlled trial of a health promotion education programme for people with multiple sclerosis. Clin. Rehabil. 20(9), 783–792 (2006).
   PubMed Web of Science ®Google Scholar
• Kasper J, Heesen C, Mühlhauser I. Evidence-based patient information: the example of immunotherapy for patients with multiple sclerosis. Bundesgesundheitsblatt. Gesundheitsforschung. Gesundheitsschutz 52(1), 77–85 (2009).
   Google Scholar
• Köpke S, Kasper J, Mühlhauser I, Nübling M, Heesen C. Patient education program to enhance decision autonomy in multiple sclerosis relapse management: a randomized-controlled trial. Mult. Scler. 15(1), 96–104 (2009).
   PubMed Web of Science ®Google Scholar
• O’Hara L, Cadbury H, De SL, Ide L. Evaluation of the effectiveness of professionally guided self-care for people with multiple sclerosis living in the community: a randomized controlled trial. Clin. Rehabil. 16(2), 119–128 (2002).
   PubMed Web of Science ®Google Scholar
• Solari A, Martinelli V, Trojano M et al; SIMS-Trial group. An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care. Mult. Scler. 16(11), 1393–1405 (2010).
   PubMed Web of Science ®Google Scholar
• Beck AT, Rush AJ, Shaw B, Emery G. Cognitive Therapy of Depression. Guilford, NY, USA (1979).
   Google Scholar
• Mohr DC. The Stress and Mood Management Program for Individuals with Multiple Sclerosis: Therapist Guide. Oxford Press, NY, USA (2010).
   Google Scholar
• Thomas PW, Thomas S, Hillier C, Galvin K, Baker R. Psychological interventions for multiple sclerosis. Cochrane Database Syst. Rev. 1, CD004431 (2006).
   PubMed Web of Science ®Google Scholar
• Dennison L, Moss-Morris R. Cognitive-behavioral therapy: what benefits can it offer people with multiple sclerosis? Expert Rev. Neurother. 10(9), 1383–1390 (2010).
   PubMed Web of Science ®Google Scholar
• Grossman P, Kappos L, Gensicke H et al. MS quality of life, depression, and fatigue improve after mindfulness training: a randomized trial. Neurology 75(13), 1141–1149 (2010).
   PubMed Web of Science ®Google Scholar
• Mohr DC, Lovera J, Brown T et al. A randomized trial of stress management for the prevention of new brain lesions in MS. Neurology 79(5), 412–419 (2012).
   PubMed Web of Science ®Google Scholar
• van Kessel K, Moss-Morris R, Willoughby E, Chalder T, Johnson MH, Robinson E. A randomized controlled trial of cognitive behavior therapy for multiple sclerosis fatigue. Psychosom. Med. 70(2), 205–213 (2008).
   Google Scholar
• Harrison V, Proudfoot J, Wee PP, Parker G, Pavlovic DH, Manicavasagar V. Mobile mental health: review of the emerging field and proof of concept study. J. Ment. Health 20(6), 509–524 (2011).
   PubMed Web of Science ®Google Scholar
• Kabat-Zinn J, Massion AO, Kristeller J et al. Effectiveness of a meditation-based stress reduction program in the treatment of anxiety disorders. Am. J. Psychiatry 149(7), 936–943 (1992).
   PubMed Web of Science ®Google Scholar
• Mohr DC, Burke H, Beckner V, Merluzzi N. A preliminary report on a skills-based telephone-administered peer support programme for patients with multiple sclerosis. Mult. Scler. 11(2), 222–226 (2005).
   PubMed Web of Science ®Google Scholar
• Mohr DC, Cox D, Merluzzi N. Self-injection anxiety training: a treatment for patients unable to self-inject injectable medications. Mult. Scler. 11(2), 182–185 (2005).
   PubMed Web of Science ®Google Scholar
• Mohr DC, Epstein L, Luks TL et al. Brain lesion volume and neuropsychological function predict efficacy of treatment for depression in multiple sclerosis. J. Consult. Clin. Psychol. 71(6), 1017–1024 (2003).
   Google Scholar
• Messmer Uccelli M, Mancuso Mohr L, Battaglia MA, Zagami P, Mohr DC. Peer support groups in multiple sclerosis: current effectiveness and future directions. Mult. Scler. 10(1), 80–84 (2004).
   Google Scholar
• das Nair R, Ferguson H, Stark DL, Lincoln NB. Memory rehabilitation for people with multiple sclerosis. Cochrane Database Syst. Rev. 3, CD008754 (2012).
   Google Scholar
• Rosti-Otajärvi EM, Hämäläinen PI. Neuropsychological rehabilitation for multiple sclerosis. Cochrane Database Syst. Rev. 11, CD009131 (2011).
   Google Scholar
• Gold SM, Mohr DC, Huitinga I, Flachenecker P, Sternberg EM, Heesen C. The role of stress-response systems for the pathogenesis and progression of MS. Trends Immunol. 26(12), 644–652 (2005).
   PubMed Web of Science ®Google Scholar
• Wüst S, van den Brandt J, Tischner D et al. Peripheral T cells are the therapeutic targets of glucocorticoids in experimental autoimmune encephalomyelitis. J. Immunol. 180(12), 8434–8443 (2008).
   PubMed Web of Science ®Google Scholar
• van den Brandt J, Lühder F, McPherson KG et al. Enhanced glucocorticoid receptor signaling in T cells impacts thymocyte apoptosis and adaptive immune responses. Am. J. Pathol. 170(3), 1041–1053 (2007).
   Google Scholar
• Gold SM, Sasidhar MV, Lagishetty V et al. Dynamic development of glucocorticoid resistance during autoimmune neuroinflammation. J. Clin. Endocrinol. Metab. doi:10.1210/jc.2012-1294 (2012) (Epub ahead of print).
   Google Scholar
• Miller GE, Chen E. Life stress and diminished expression of genes encoding glucocorticoid receptor and beta2-adrenergic receptor in children with asthma. Proc. Natl Acad. Sci. USA 103(14), 5496–5501 (2006).
   PubMed Web of Science ®Google Scholar
• Stark JL, Avitsur R, Padgett DA, Campbell KA, Beck FM, Sheridan JF. Social stress induces glucocorticoid resistance in macrophages. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280(6), R1799–R1805 (2001).
   PubMed Web of Science ®Google Scholar
• Quan N, Avitsur R, Stark JL et al. Molecular mechanisms of glucocorticoid resistance in splenocytes of socially stressed male mice. J. Neuroimmunol. 137(1–2), 51–58 (2003).
   PubMed Web of Science ®Google Scholar
• Ziemssen T. Multiple sclerosis beyond EDSS: depression and fatigue. J. Neurol. Sci. 277(Suppl. 1), S37–S41 (2009).
   Google Scholar
• Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol. 7(12), 1139–1151 (2008).
   PubMed Web of Science ®Google Scholar
• Mohr DC, Goodkin DE, Islar J, Hauser SL, Genain CP. Treatment of depression is associated with suppression of nonspecific and antigen-specific T(H)1 responses in multiple sclerosis. Arch. Neurol. 58(7), 1081–1086 (2001).
   PubMed Web of Science ®Google Scholar
• Luders E, Clark K, Narr KL, Toga AW. Enhanced brain connectivity in long-term meditation practitioners. Neuroimage 57(4), 1308–1316 (2011).
   PubMed Web of Science ®Google Scholar
• Luders E, Kurth F, Mayer EA, Toga AW, Narr KL, Gaser C. The unique brain anatomy of meditation practitioners: alterations in cortical gyrification. Front. Hum. Neurosci. 6, 34 (2012).
   PubMed Web of Science ®Google Scholar
• Luders E, Phillips OR, Clark K, Kurth F, Toga AW, Narr KL. Bridging the hemispheres in meditation: thicker callosal regions and enhanced fractional anisotropy (FA) in long-term practitioners. Neuroimage 61(1), 181–187 (2012).
   PubMed Web of Science ®Google Scholar
• Luders E, Toga AW, Lepore N, Gaser C. The underlying anatomical correlates of long-term meditation: larger hippocampal and frontal volumes of gray matter. Neuroimage 45(3), 672–678 (2009).
   PubMed Web of Science ®Google Scholar
• Hölzel BK, Ott U, Gard T et al. Investigation of mindfulness meditation practitioners with voxel-based morphometry. Soc. Cogn. Affect. Neurosci. 3(1), 55–61 (2008).
   PubMed Web of Science ®Google Scholar
• Sicotte NL, Kern KC, Giesser BS et al. Regional hippocampal atrophy in multiple sclerosis. Brain 131(Pt 4), 1134–1141 (2008).
   PubMed Web of Science ®Google Scholar
• Gold SM, Kern KC, O’Connor MF et al. Smaller cornu ammonis (CA) 2–3 / dentate gyrus volumes and elevated cortisol in multiple sclerosis patients with depressive symptoms. Biol. Psychiatry 68(6), 553–559 (2010).
   PubMed Web of Science ®Google Scholar
• Kiy G, Lehmann P, Hahn HK, Eling P, Kastrup A, Hildebrandt H. Decreased hippocampal volume, indirectly measured, is associated with depressive symptoms and consolidation deficits in multiple sclerosis. Mult. Scler. 17(9), 1088–1097 (2011).
   PubMed Web of Science ®Google Scholar
• Pedersen BK. Exercise-induced myokines and their role in chronic diseases. Brain Behav. Immun. 25(5), 811–816 (2011).
   PubMed Web of Science ®Google Scholar
• Cotman CW, Berchtold NC, Christie LA. Exercise builds brain health: key roles of growth factor cascades and inflammation. Trends Neurosci. 30(9), 464–472 (2007).
   PubMed Web of Science ®Google Scholar
• Gold SM, Schulz KH, Hartmann S et al. Basal serum levels and reactivity of nerve growth factor and brain-derived neurotrophic factor to standardized acute exercise in multiple sclerosis and controls. J. Neuroimmunol. 138(1–2), 99–105 (2003).
   PubMed Web of Science ®Google Scholar
• Gleeson M, Bishop NC, Stensel DJ, Lindley MR, Mastana SS, Nimmo MA. The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat. Rev. Immunol. 11(9), 607–615 (2011).
   PubMed Web of Science ®Google Scholar
• Petajan JH, Gappmaier E, White AT, Spencer MK, Mino L, Hicks RW. Impact of aerobic training on fitness and quality of life in multiple sclerosis. Ann. Neurol. 39(4), 432–441 (1996).
   PubMed Web of Science ®Google Scholar
• Romberg A, Virtanen A, Ruutiainen J et al. Effects of a 6-month exercise program on patients with multiple sclerosis: a randomized study. Neurology 63(11), 2034–2038 (2004).
   PubMed Web of Science ®Google Scholar
• Schwartz CE. Teaching coping skills enhances quality of life more than peer support: results of a randomized trial with multiple sclerosis patients. Health Psychol. 18(3), 211–220 (1999).
   PubMed Web of Science ®Google Scholar
• Lincoln NB, Dent A, Harding J et al. Evaluation of cognitive assessment and cognitive intervention for people with multiple sclerosis. J. Neurol. Neurosurg. Psychiatr. 72(1), 93–98 (2002).
   PubMed Web of Science ®Google Scholar
• Stuifbergen AK, Becker H, Blozis S, Timmerman G, Kullberg V. A randomized clinical trial of a wellness intervention for women with multiple sclerosis. Arch. Phys. Med. Rehabil. 84(4), 467–476 (2003).
   PubMed Web of Science ®Google Scholar
• Rigby S. Coping With MS. University of Liverpool, Liverpool, UK (2003).
   Google Scholar
• Mathiowetz VG, Finlayson ML, Matuska KM, Chen HY, Luo P. Randomized controlled trial of an energy conservation course for persons with multiple sclerosis. Mult. Scler. 11(5), 592–601 (2005).
   PubMed Web of Science ®Google Scholar